Muscle relaxant drugs.
D000328:Adult; D000368:Aged; D000443:Alcuronium / Q000494:pharmacology; D002648:Child; D004347:Drug Interactions; D004363:Drug Utilization; D005260:Female; D005703:Gallamine Triethiodide / Q000494:pharmacology; D006801:Humans; D007231:Infant, Newborn; D007674:Kidney Diseases / Q000378:metabolism; D008107:Liver Diseases / Q000378:metabolism; D008431:Maternal-Fetal Exchange; D009466:Neuromuscular Blocking Agents / Q000378:metabolism / Q000494:pharmacology*; D009467:Neuromuscular Depolarizing Agents / Q000378:metabolism / Q000494:pharmacology*; D009468:Neuromuscular Diseases / Q000378:metabolism; D009469:Neuromuscular Junction / Q000502:physiology; D010197:Pancuronium / Q000494:pharmacology; D011247:Pregnancy; D011726:Pyridinium Compounds / Q000494:pharmacology; D013390:Succinylcholine / Q000009:adverse effects / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects; D014403:Tubocurarine / Q000009:adverse effects / Q000494:pharmacology
D009466:Neuromuscular Blocking Agents; D009467:Neuromuscular Depolarizing Agents; D011726:Pyridinium Compounds; D013390:Succinylcholine; D010197:Pancuronium; D005703:Gallamine Triethiodide; D000443:Alcuronium; D014403:Tubocurarine